KFDA label changes for 16 active ingredients including Reductil

Published: 2006-05-17 07:00:00

Updated: 2006-05-17 07:00:00

The KFDA announced on May 12 that the labels of drugs containing 16 active ingredients including sibutramine (Reductil) had been changed. The label changes included warning descriptions for Reductil that may happen to cause hypertension, headache and dizziness. Reductil (Abbott) was contra-indicated to the advanced patients under the treatment of kidney dialysis.

The label changes for Xatral...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.